EAP deal structures are where good headline numbers become good outcomes — or quietly stop being good. Most owners sell once, while every buyer across the table structures acquisitions for a living, and the vocabulary gap between them is expensive. This guide translates every major term you’ll meet in an offer for your EAP business into plain English, with the EAP-specific wrinkles — like employer-contract consent requirements — that generalist explainers miss.
Every deal starts with a legal-structure question. In an asset sale, the buyer purchases the business’s assets — contracts, brand, systems, network agreements — into their own entity, typically preferring this route for its tax treatment and its ability to leave historical liabilities behind. In a stock (equity) sale, the buyer acquires your entity itself, with everything inside it.
For EAP owners the fork has a specific consequence: contract assignment. In an asset sale, employer contracts generally must be assigned to the buyer’s entity — and many contain clauses requiring client consent to that assignment. A stock sale can avoid triggering pure assignment clauses, but change-of-control provisions may apply regardless. This single mechanical difference reshapes timelines, communication plans, and sometimes price. Map your clauses before you negotiate structure, not after — it’s step seven in our pre-sale preparation guide.
An earnout pays part of the price later, contingent on performance after close. In EAP deals, earnouts most often attach to contract renewals or revenue retention — the buyer’s way of sharing the risk that your book transfers intact.
A fair earnout has three properties: targets tied to metrics you can still influence after close, measurement definitions written precisely into the agreement, and a duration short enough that the buyer’s own post-close decisions don’t dominate the outcome. The trap versions fail those tests — targets defined on the buyer’s blended financials, metrics the buyer’s integration choices control, or horizons long enough for strategy changes to strand your payments. Earnouts aren’t inherently bad; unexamined ones are.
Rollover equity means taking part of your price as ownership in the acquiring platform rather than cash. When the platform itself later sells — typically at the platform multiples covered in EAP EBITDA Multiples — your retained stake participates: the “second bite of the apple” that has produced some of the best total outcomes across consolidating healthcare sectors.
The diligence burden runs toward you, though: a rollover makes you a minority investor in someone else’s company. Evaluate the platform’s leverage, governance terms, and track record with prior sellers’ equity — and treat glossy projections the way buyers treat yours.
Three smaller terms that move real money. A seller note is financing you extend to the buyer — part of the price paid over time with interest; its value depends entirely on the buyer’s creditworthiness and the note’s seniority. The working-capital peg defines how much operating capital must remain in the business at close; for EAPs, deferred revenue on annually billed contracts makes this negotiation unusually consequential, because prepaid-but-unearned revenue can be treated as a liability you’re leaving behind. Escrows and holdbacks park part of the price against post-close claims — standard practice, but cap, duration, and release conditions are all negotiable.
The letter of intent sets headline price, structure, and — critically — exclusivity: once signed, your competitive process pauses and your leverage shifts to the buyer. That’s why experienced sellers negotiate key structural terms into the LOI itself, while competition still exists, rather than deferring them to the definitive purchase agreement where reps, warranties, indemnification, and every mechanism above get papered in full. The moment to be demanding is before exclusivity, not after.
Retention pools for key clinicians and account staff, transition employment terms, and clinical-model commitments can all be written into the deal — and in a relationship business they protect value for both sides. Owners who raise these terms early get them; owners who assume goodwill will handle it are trusting the one document that doesn’t exist. Context on why this matters — and how to vet a buyer’s track record — is in What Buyers Look for in EAP Businesses.
Because employer contracts are the asset in an EAP transaction, consent mechanics deserve their own plan rather than a paragraph in someone else’s checklist. The sequence that works: inventory every contract’s assignment and change-of-control language before going to market; group clients into consent-required, notice-only, and silent categories; negotiate deal structure with that map on the table (it’s a legitimate argument for a stock sale, or for closing conditions that don’t hinge on 100% consent); and script the client conversations — who calls, when, with what continuity commitments — so your anchor employers hear a plan, not a rumor. Buyers respect sellers who arrive with this done; it signals exactly the operational discipline they’re paying for. Handled late, the same clauses become the deal’s longest delay and occasionally its repricing excuse.
Two offers, same $8M headline. Offer A: $7M cash at close, $1M earnout on renewals you’ll still manage, standard escrow. Offer B: $4.5M cash, $2M earnout on the buyer’s post-integration revenue, $1.5M rollover into a highly leveraged platform, and a working-capital peg left “to be agreed.” These are not the same offer — A is worth close to its headline; B might outperform it or might deliver $4.5M and paper. Structure is the offer. Price is just its first line. The traps hiding in offers like B are cataloged in Avoiding Common Pitfalls When Selling Your EAP Business.
Structure conversations start from a number — get yours from the EAP business valuation calculator, then see the full process in How to Sell an EAP Business: The Complete Owner’s Guide. Holding an offer letter right now? Have it reviewed before you sign anything with an exclusivity clause.